Literature DB >> 29135797

USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA.

Celine Pochat-Cotilloux1, Jacques Bienvenu2, Anh-Minh Nguyen1, Robin Ohanessian3, Hervé Ghesquières4, Pascal Sève5, Lorna Garnier2, Laurent Kodjikian1,6.   

Abstract

PURPOSE: To determine a threshold for interleukin (IL)-10 and IL-10/IL-6 ratio in the aqueous humor (AH) and the vitreous for the screening of vitreoretinal lymphoma (VRL).
METHODS: One hundred nineteen patients for whom IL-10 and IL-6 in the AH and/or vitreous had been measured were included: 16 patients with a final diagnosis of VRL and 103 patients with final diagnosis of uveitis. Groups were compared according to IL-10 and IL-6 levels and demographic data.
RESULTS: In patients with VRL (Group 1), mean IL-10 values were 5,636 pg/mL, and in patients with uveitis (Group 2), 6.7 pg/mL in the vitreous and 190 pg/mL in Group 1 and 8.6 pg/mL in the AH. In Group 1, the mean IL-10/IL-6 ratio was 29.02 in the vitreous and 10.9 in the AH; in Group 2, ratio was 0.1 in both humors. These values were significantly different between patients with VRL and with uveitis (P < 0.001). A cutoff of 65 pg/mL and 30 pg/mL IL-10 in the vitreous and AH, respectively, was associated with sensitivity of 93% and 78%, respectively, and specificity of 100% and 97%, respectively. A ratio higher than 1 in the vitreous had sensitivity of 93% and specificity of 100%.
CONCLUSION: Vitreoretinal lymphoma diagnosis is difficult, and tools like interleukin measurements in AH and vitreous can make it easier. The use of a cutoff for IL-10 and IL-10/IL-6 ratio could allow for an earlier diagnosis that may improve prognosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29135797     DOI: 10.1097/IAE.0000000000001922

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

Review 1.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

Review 2.  Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!

Authors:  Maxime Fontanilles; Alberto Duran-Peña; Ahmed Idbaih
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-09       Impact factor: 5.081

Review 3.  Vitreoretinal surgery in the management of infectious and non-infectious uveitis - a narrative review.

Authors:  Jia-Horung Hung; Narsing A Rao; Wei-Chun Chiu; Shwu-Jiuan Sheu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-12       Impact factor: 3.535

4.  High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.

Authors:  Jie Shao; Kun Chen; Qing Li; Jingjing Ma; Yan Ma; Zhiguang Lin; Hui Kang; Bobin Chen
Journal:  Cancer Manag Res       Date:  2020-07-24       Impact factor: 3.989

Review 5.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10

Review 6.  Interleukins and cytokine biomarkers in uveitis.

Authors:  S Balamurugan; Dipankar Das; Murat Hasanreisoglu; Brian C Toy; Mashal Akhter; V K Anuradha; Eliza Anthony; Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 7.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

8.  High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.

Authors:  Teruumi Minezaki; Yoshihiko Usui; Masaki Asakage; Masakatsu Takanashi; Hiroyuki Shimizu; Naoya Nezu; Akitomo Narimatsu; Kinya Tsubota; Kazuhiko Umazume; Naoyuki Yamakawa; Masahiko Kuroda; Hiroshi Goto
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

9.  Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.

Authors:  Young Gun Park; Woo-Kyung Park; Rae-Young Kim; Mirinae Kim; Young-Hoon Park
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

10.  IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.

Authors:  Rita Mancini; Marshall E Kadin; Arianna Di Napoli; Daniele Greco; Giorgia Scafetta; Francesca Ascenzi; Alessandro Gulino; Luigi Aurisicchio; Fabio Santanelli Di Pompeo; Adriana Bonifacino; Enrico Giarnieri; John Morgan
Journal:  Cancer Immunol Immunother       Date:  2020-11-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.